Humacyte Inc (HUMA)

Is Humacyte Inc (HUMA) A Buy Now?

According to our latest analysis, HUMA could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 11 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on HUMA, as trading bearish markets can be challenging and may result in losses.

1. RSI (Relative Strength Index): The RSI(14) value of 41.84 indicates that HUMA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
2. STOCH (Stochastic Oscillator): The STOCH value of 64.83 indicates that HUMA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 71.53 indicates that HUMA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
4. ADX (Average Directional Index): The ADX value of 26.47 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
5. CCI (Commodity Channel Index): A CCI(14) value of 9.72 indicates that HUMA is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term HUMA price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Humacyte Inc financial reports and earnings history, Humacyte Inc (HUMA) stock could reach $2.77 by 2030, $18.14 by 2040 and $41.68 by 2050. See the projected annual prices until 2050 of the Humacyte Inc stock below:

• Humacyte Inc (HUMA) is expected to reach an average price of $3.52 in 2035, with a high prediction of $9.19 and a low estimate of $1.84. This indicates an +755.73% change from the last recorded price of $0.4112.
• Humacyte Inc (HUMA) stock is projected to chart a bullish course in 2040, with an average price target of $11.55, representing an +2,710% change from its current level. The forecast ranges from a conservative $12.03 to a sky-high $18.14.
• Our analysts predict Humacyte Inc (HUMA) to change +5,523% by 2045, soaring from $22.83 to an average price of $23.12, potentially reaching $29.78. While $22.83 is the low estimate, the potential upside is significant.
• Humacyte Inc (HUMA) stock is expected to climb by 2050, reaching an average of $35.11, a +8,438% change from its current level. However, a wide range of estimates exists, with high and low targets of $41.68 and $35.31, respectively, highlighting the market's uncertainty.

Humacyte Inc Stock (HUMA) Year by Year Forecast